Matinas BioPharma Holdings Inc R&D Day Transcript
Hello, and welcome to the Matinas BioPharma R&D Day Conference Call and Webcast. If you have not already done so, please close all other programs on your computer. (Operator Instructions)
I will now turn our webcast over to Jerry Jabbour, Chief Executive Officer of Matinas BioPharma. Please go ahead.
Thank you, Jesse. Before I begin, I would like to remind everyone that today's presentation will include forward-looking statements. Please see Slide 3 and our SEC filings for a discussion about important risk factors relating to these forward-looking statements.
Now with that formality out of the way, good morning, and welcome to Matinas' very first R&D Day. We are delighted that you are taking the time to join us today. Today's presentations and materials come at an extremely exciting and important time for our company. Our recent strategic decision to focus our internal expertise and resources on our lipid nanocrystal, or LNC, platform and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |